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Selenium deficiency has been suggested by several studies
to be associated with cancer risk. We conducted a case-
control study in Szczecin, a region of northwestern
Poland, on 86 cases of lung cancer, 87 cases of laryngeal
cancer and an equal number of healthy controls. We stu-
died the serum level of selenium and genotypes for four
variants in four selenoprotein genes (GPX1, GPX4,
TXNRD2 and SEP15) and the odds of being diagnosed
with lung or laryngeal cancer.
Among lung cancer cases, the mean selenium level was
63.2 µg/l, compared to a mean level of 74.7 µg/l for their
matched controls (p < 0.0001). Among laryngeal cancer
cases, the mean selenium level was 64.8 µg/l, compared to
a mean level of 76.3 µg/l for their matched controls (p <
0.0001). Compared to a serum selenium value in the low-
est of four categories (≤ 60 µg/l) a selenium level in the
highest category (> 80 µg/l) was associated with an odds
ratio of 0.10 (95% CI 0.03 to 0.34; p = 0.0002) for lung
cancer and 0.24 (95% CI 0.10 to 0.59; p = 0.002) for laryn-
geal cancer. In four selenoproteins studied here we found
a modest associations of genetic variants in GPX1 and
GPX4 with lung and TXNRD2 with laryngeal cancer risk.
We analyzed iron (Fe) level in serum of 77 lung cancer
patients and 77 matched controls. We did not find differ-
ence in mean Fe level between cases and controls (1053.05
µg/l and 1059.39 µg/l). However, we found that Fe level in
the lowest and highest quartiles was associated with a sig-
nificant lung risk enhancement when compared to a
serum Fe level in the middle quartiles (OR 0.3, p 0.02).
We also observed that the relationship between the level
of Fe and Se could be an important factor for lung cancer
risk.
Conclusion
1. Se is the strong marker of high risk of lung and lar-
yngeal cancers and can be potentially used for detection
of early cancers. Based on data showing higher Se supple-
mentation as to be associated with lower cancer mortality
(OR.55) Se supplementation should be considered to all
patients with already diagnosed cancer.
2. Very low and very high Fe level seems to be asso-
ciated with increased lung cancer risk
3. Most probably, for exact cancer risk assessment it
will be necessary to analyze relationships between
microelements, ie. Fe/Se ratio.
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